These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23596320)

  • 21. Pentavalent rotavirus vaccine in infants with surgical gastrointestinal disease.
    McGrath EJ; Thomas R; Duggan C; Asmar BI
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):44-8. PubMed ID: 24614127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjects.
    Lawrence J; He S; Martin J; Schödel F; Ciarlet M; Murray AV
    Hum Vaccin Immunother; 2014; 10(8):2247-54. PubMed ID: 25424929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice.
    Maier EA; Weage KJ; Guedes MM; Denson LA; McNeal MM; Bernstein DI; Moore SR
    Vaccine; 2013 Dec; 32(1):48-53. PubMed ID: 24200975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines.
    Moon SS; Wang Y; Shane AL; Nguyen T; Ray P; Dennehy P; Baek LJ; Parashar U; Glass RI; Jiang B
    Pediatr Infect Dis J; 2010 Oct; 29(10):919-23. PubMed ID: 20442687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.
    Angel J; Steele AD; Franco MA
    Hum Vaccin Immunother; 2014; 10(12):3659-71. PubMed ID: 25483685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
    Chen MY; Kirkwood CD; Bines J; Cowley D; Pavlic D; Lee KJ; Orsini F; Watts E; Barnes G; Danchin M
    Hum Vaccin Immunother; 2017 May; 13(5):1126-1135. PubMed ID: 28059609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
    Vesikari T; Prymula R; Schuster V; Tejedor JC; Cohen R; Bouckenooghe A; Damaso S; Han HH
    Pediatr Infect Dis J; 2012 May; 31(5):509-13. PubMed ID: 22228235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter.
    Wang X; Velasquez Portocarrero DE; Cortese MM; Parashar U; Zaman K; Jiang B
    Hum Vaccin Immunother; 2023 Dec; 19(1):2167437. PubMed ID: 36715015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
    Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
    Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotavirus Serum IgA Immune Response in Children Receiving Rotarix Coadministered With bOPV or IPV.
    Ramani S; Mamani N; Villena R; Bandyopadhyay AS; Gast C; Sato A; Laucirica D; Clemens R; Estes MK; O'Ryan ML
    Pediatr Infect Dis J; 2016 Oct; 35(10):1137-9. PubMed ID: 27254033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotavirus vaccination and infection induce VP6-specific IgA responses.
    Lappalainen S; Blazevic V; Malm M; Vesikari T
    J Med Virol; 2017 Feb; 89(2):239-245. PubMed ID: 27431308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.
    Wen X; Wen K; Cao D; Li G; Jones RW; Li J; Szu S; Hoshino Y; Yuan L
    Vaccine; 2014 Jul; 32(35):4420-4427. PubMed ID: 24962749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine.
    Rojas OL; Caicedo L; Guzmán C; Rodríguez LS; Castañeda J; Uribe L; Andrade Y; Pinzón R; Narváez CF; Lozano JM; De Vos B; Franco MA; Angel J
    Viral Immunol; 2007; 20(2):300-11. PubMed ID: 17603846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.
    Velasquez-Portocarrero DE; Wang X; Cortese MM; Snider CJ; Anand A; Costantini VP; Yunus M; Aziz AB; Haque W; Parashar U; Sisay Z; Soeters HM; Hyde TB; Jiang B; Zaman K
    Lancet Infect Dis; 2022 Nov; 22(11):1606-1616. PubMed ID: 35961362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial.
    Ali SA; Kazi AM; Cortese MM; Fleming JA; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi A
    J Infect Dis; 2014 Dec; 210(11):1772-9. PubMed ID: 24939906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary rice bran protects against rotavirus diarrhea and promotes Th1-type immune responses to human rotavirus vaccine in gnotobiotic pigs.
    Yang X; Wen K; Tin C; Li G; Wang H; Kocher J; Pelzer K; Ryan E; Yuan L
    Clin Vaccine Immunol; 2014 Oct; 21(10):1396-403. PubMed ID: 25080551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine.
    Ward RL; Bernstein DI; Smith VE; Sander DS; Shaw A; Eiden JJ; Heaton P; Offit PA; Clark HF
    J Infect Dis; 2004 Jun; 189(12):2290-3. PubMed ID: 15181577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.
    Rha B; Tate JE; Payne DC; Cortese MM; Lopman BA; Curns AT; Parashar UD
    Expert Rev Vaccines; 2014 Mar; 13(3):365-76. PubMed ID: 24392657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.